Krystal Biotech stockKRYS
Krystal Biotech trades at $300.25, 21.5% below its 52-week high (Jun 30, 2026). The price is below its 50- and 200-day averages, a downtrend. +21.8% year to date, +50.2% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Mar 1, 2027.
Ratings, candles, signals and the screener for KRYS — after you log in
Open the terminalFrequently asked questions about Krystal Biotech
What is the Krystal Biotech stock price?
At the close on Nov 5, 2026: $300.25 (−3.41% on the day). 52-week high: $382.54 on Jun 30, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Krystal Biotech report earnings?
The next quarterly report is on Mar 1, 2027. Last quarter, earnings per share changed −23% year over year, revenue +30%.
Does Krystal Biotech pay dividends?
No, Krystal Biotech does not pay dividends.
Where does Krystal Biotech trade and how to buy it?
Ticker KRYS, exchange Nasdaq, listed since 2017. You can buy it through a broker with access to US exchanges.
Should I buy Krystal Biotech now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for KRYS are in the terminal after you log in.